S1P is associated with protection in human and experimental cerebral malaria - Wikidata - wikimedia - TriplyDB

S1P is associated with protection in human and experimental cerebral malaria

S1P is associated with protection in human and experimental cerebral malaria

http://www.wikidata.org/entity/Q35136728

about

Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain Tonic regulation of vascular permeability Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)Vascular dysfunction as a target for adjuvant therapy in cerebral malaria Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier Neuroimmunological blood brain barrier opening in experimental cerebral malaria Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.Imaging Plasmodium immunobiology in the liver, brain, and lung.Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome.Reduction in serum sphingosine 1-phosphate concentration in malaria.Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.Sphingosine 1-phosphate in acute dengue infection Artesunate Protected Blood-Brain Barrier via Sphingosine 1 Phosphate Receptor 1/Phosphatidylinositol 3 Kinase Pathway After Subarachnoid Hemorrhage in Rats.Erythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels.Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier.miR-155 Modifies Inflammation, Endothelial Activation and Blood-Brain Barrier Dysfunction in Cerebral Malaria.Immunobiology of Plasmodium in liver and brain.Emerging therapeutic strategies to prevent infection-related microvascular endothelial activation and dysfunction.The immunological balance between host and parasite in malaria.Biomarkers of hypoxia, endothelial and circulatory dysfunction among climbers in Nepal with AMS and HAPE: a prospective case-control study.Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria.A single rapamycin dose protects against late-stage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration.Fingolimod affects gene expression profile associated with LPS-induced memory impairment.FTY720 restores endothelial cell permeability induced by malaria sera The biological basis and clinical symptoms of CAR-T therapy-associated toxicites

P2860

Q26778543-659809FD-AB76-40F3-BED3-F7DCB689F03A Q26863424-419BF68A-4217-45BB-842B-C91864841034 Q27000801-D2F8FE24-C4F3-49FD-AA04-E34D56DCC10F Q27025436-EA10D977-7A51-4ABF-A1F5-8CD81594DB43 Q27322655-43D2CBC1-4D31-4795-9F61-1E0B86869666 Q27341951-7AB09952-732B-4ADC-999F-514284A020A3 Q28080030-34189FCA-5B3A-407A-AD64-09B9AB279F6E Q30457536-14493728-A0CF-40D1-89C5-D3C1F7A8E843 Q30561036-ADBF6D9C-AE5C-42DB-AB8F-10931AB36F3A Q33408673-7DD96334-E3DA-472C-92BC-CA6788828C63 Q33443159-9954F5FC-31BE-4533-8927-5FCC9B52EE63 Q34364844-34460408-C965-4E73-897A-90EB396BAD4E Q35435898-A0E628FA-7C39-4E11-8784-4825813D27F0 Q35907126-4209FD75-5C25-45E0-AEB2-30A96F1114DC Q36312740-ACCABD05-8616-4A5C-8F28-9E25FBF34C0C Q37065724-4E680EEA-03B8-428B-9F37-AD23BAA5CF68 Q37209163-686A79D3-B111-474B-9B07-01196F9FA047 Q37466271-3F7D4922-736A-4061-A8D3-142A21CA6AA5 Q37548166-A019B22D-3DE9-489C-9F73-71E7E7F480F3 Q37713193-199C5482-764A-45D4-8A84-0F1BE2165465 Q37718931-513725A1-0001-4506-BFCA-B0B6D78D7CD1 Q38103059-7E9D5220-4EDA-4FDA-8DB8-7A7D45670646 Q38122283-E4E9C094-1BA6-438D-B7F1-F2AEB46593FB Q38666558-83C5A121-9718-4966-97F8-835C602B4E19 Q38893539-29DF577F-8C02-443C-BBC0-EF8FE7908746 Q42929711-BA9F93EC-5E77-4BC4-AFC8-3B77A9218637 Q45330025-97C718B0-382B-400B-984B-712DE86ACBE6 Q48618760-6E670FD8-081F-4CED-9356-32741DAF06E5 Q56361078-2B821F8C-AA9C-4A2A-9EF5-0A29111C3A3B Q58765358-5CBD10AC-92D2-46DE-94C8-11CA74DA9C89

P2860

S1P is associated with protection in human and experimental cerebral malaria

http://www.wikidata.org/entity/Q35136728

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

S1P is associated with protection in human and experimental cerebral malaria

@ast

S1P is associated with protection in human and experimental cerebral malaria

@en

type

label

S1P is associated with protection in human and experimental cerebral malaria

@ast

S1P is associated with protection in human and experimental cerebral malaria

@en

prefLabel

S1P is associated with protection in human and experimental cerebral malaria

@ast

S1P is associated with protection in human and experimental cerebral malaria

@en

P1433

Q35136728-6BA5DFA1-590D-4A86-8BEE-477FF3A69233

P1476

Q35136728-F103A46C-F465-4233-97E6-3579FB12F7E5

P2093

Q35136728-3F3A0C18-C3E5-4151-93B7-0C19B706FA86

Q35136728-514F3F43-6BA7-49A2-B485-04BA2B4DB1AC

Q35136728-619DA18E-FD5C-42B8-A58F-C0087E4422D6

Q35136728-91824521-E128-4BD8-8AAD-2124BA2B1F14

Q35136728-C42A36AE-A12A-4A6B-90F6-293667AE0236

Q35136728-C577ECE5-2D4F-43F7-B259-5B23C64DCE53

Q35136728-CC5D7C9B-C49E-4552-A243-C2F53264774E

Q35136728-F5C04411-8B5E-40B2-B25E-E2D3F989ED4D

P2860

Q35136728-0185DDCB-09DE-4764-AC19-EECC8FE71ACE

Q35136728-01CBFD4C-0BAF-4A51-8238-DC573920B2B4

Q35136728-0284E07F-AB3A-4C28-A2A1-9CF312829751

Q35136728-084BA5EC-43B7-4DAD-BE46-8C229620B038

Q35136728-09342342-D957-4476-8983-7A8B8EA2DC14

Q35136728-1033CAD1-9B26-4481-A9F9-EBF82D53D732

Q35136728-154D62A3-991F-4429-B82A-D0231EA216D9

Q35136728-1BEF3102-0EFF-4875-9DFC-D79E6AAF8105

Q35136728-217016EE-911A-4F49-B607-0B147F5B46D8

Q35136728-232824E1-2C3E-4CAF-A769-865B44A19FA9

P2888

Q35136728-A149FDFD-D018-4C25-8D3F-1C4FE94A764D

P304

Q35136728-BD9A7E39-F865-4F2A-B6D3-58817D272662

P31

Q35136728-36D51104-A3E8-401F-BBBD-226B57E2DC37

P356

Q35136728-54791828-F655-495B-9BBF-AC080EEC7573

P407

Q35136728-6A625F42-C432-48C1-8CE5-038AFDDBF13E

P433

Q35136728-CB829D91-6337-4D0D-8BA2-24A8A1DA787E

P478

Q35136728-167ACB0B-5058-451A-B994-087B1AB87583

P50

Q35136728-11FA50C2-48A3-464C-A0BE-DF44EFAF00E5

P577

Q35136728-3751D682-117B-49C9-BD1F-BDB2573C2608

P5875

Q35136728-14F8FFB2-0A3A-47C7-B511-BCD648FB01D4

P6179

Q35136728-99C39CE0-D6A6-433F-BB6C-B4C6E9903916

P698

Q35136728-0C78C38A-A966-498D-BB09-6217868CA3A7

P921

Q35136728-0080F5C2-7BE9-40BE-B8D1-A3CBB7316054

Q35136728-3ED0E033-CCB1-45C5-9510-3B135BB157F8

P932

Q35136728-89E75C23-09B0-40E5-9D0F-EB386E6B4D3C

P356

MOLMED.2010.00214

P1433

Molecular Medicine

P1476

S1P is associated with protection in human and experimental cerebral malaria

@en

P2093

Aggrey Dhabangi

http://www.w3.org/2001/XMLSchema#string

Charles Musoke

http://www.w3.org/2001/XMLSchema#string

Cheryl A Hawkes

http://www.w3.org/2001/XMLSchema#string

Christine Cserti-Gazdewich

http://www.w3.org/2001/XMLSchema#string

Constance Am Finney

http://www.w3.org/2001/XMLSchema#string

Dylan C Kain

http://www.w3.org/2001/XMLSchema#string

Tamas Oravecz

http://www.w3.org/2001/XMLSchema#string

W Conrad Liles

http://www.w3.org/2001/XMLSchema#string

P2860

EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue

Astrocyte-endothelial interactions at the blood-brain barrier

Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

Sphingosine-1-phosphate: an enigmatic signalling lipid

Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.

P2888

molmed.2010.00214

P304

717-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/MOLMED.2010.00214

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51111633

http://www.w3.org/2001/XMLSchema#string

P6179

1068965328

http://www.w3.org/2001/XMLSchema#string

P698

21556483

http://www.w3.org/2001/XMLSchema#string

P921

cerebral malaria

P932

3146616

http://www.w3.org/2001/XMLSchema#string